enVVeno Medical Future Growth
Future criteria checks 2/6
enVVeno Medical is forecast to grow earnings and revenue by 32.9% and 96.7% per annum respectively while EPS is expected to grow by 41.7% per annum.
Key information
32.9%
Earnings growth rate
41.7%
EPS growth rate
| Medical Equipment earnings growth | 14.2% |
| Revenue growth rate | 96.7% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 06 Aug 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 22 | -19 | N/A | -7 | 1 |
| 12/31/2025 | 4 | -25 | N/A | 7 | 1 |
| 12/31/2024 | N/A | -22 | N/A | -24 | 1 |
| 9/30/2024 | N/A | -21 | -17 | -17 | N/A |
| 6/30/2024 | N/A | -21 | -17 | -17 | N/A |
| 3/31/2024 | N/A | -22 | -17 | -17 | N/A |
| 12/31/2023 | N/A | -24 | -19 | -19 | N/A |
| 9/30/2023 | N/A | -24 | -18 | -18 | N/A |
| 6/30/2023 | N/A | -25 | -18 | -18 | N/A |
| 3/31/2023 | N/A | -26 | -17 | -17 | N/A |
| 12/31/2022 | N/A | -25 | -16 | -16 | N/A |
| 9/30/2022 | N/A | -27 | -15 | -15 | N/A |
| 6/30/2022 | N/A | -24 | -13 | -13 | N/A |
| 3/31/2022 | N/A | -19 | -12 | -11 | N/A |
| 12/31/2021 | N/A | -17 | -12 | -12 | N/A |
| 9/30/2021 | N/A | -12 | -12 | -11 | N/A |
| 6/30/2021 | N/A | -12 | -12 | -12 | N/A |
| 3/31/2021 | N/A | -11 | -11 | -10 | N/A |
| 12/31/2020 | N/A | -10 | -8 | -8 | N/A |
| 9/30/2020 | N/A | -7 | -7 | -7 | N/A |
| 6/30/2020 | N/A | -7 | -6 | -5 | N/A |
| 3/31/2020 | N/A | -7 | -6 | -6 | N/A |
| 12/31/2019 | 0 | -8 | -6 | -6 | N/A |
| 9/30/2019 | 0 | -7 | -6 | -6 | N/A |
| 6/30/2019 | 0 | -7 | -6 | -6 | N/A |
| 3/31/2019 | 0 | -13 | -6 | -6 | N/A |
| 12/31/2018 | 0 | -16 | -6 | -6 | N/A |
| 9/30/2018 | 0 | -18 | -6 | -6 | N/A |
| 6/30/2018 | 0 | -19 | N/A | -6 | N/A |
| 3/31/2018 | 0 | -12 | N/A | -5 | N/A |
| 12/31/2017 | 0 | -8 | N/A | -4 | N/A |
| 9/30/2017 | 1 | -7 | N/A | -4 | N/A |
| 6/30/2017 | 1 | -5 | N/A | -3 | N/A |
| 3/31/2017 | 1 | -6 | N/A | -3 | N/A |
| 12/31/2016 | 1 | -6 | N/A | -3 | N/A |
| 9/30/2016 | 0 | -5 | N/A | -4 | N/A |
| 12/31/2015 | N/A | -1 | N/A | -2 | N/A |
| 12/31/2014 | 0 | -1 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 5HJ is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 5HJ is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 5HJ is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 5HJ's revenue (96.7% per year) is forecast to grow faster than the German market (5.7% per year).
High Growth Revenue: 5HJ's revenue (96.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 5HJ's Return on Equity is forecast to be high in 3 years time